Provenance Precision Medicine Foundation

Engaged a consultant to initiate research and strategic planning to support access to cancer vaccine clinical trials in the United States. Two board members also traveled to Germany to meet with researchers and clinicians as part of this effort. These activities are part of the Foundation's ongoing work to expand the availability of innovative immunotherapies for patients with advanced cancer.

Contracted a consultant to create patient education materials focused on vaccine treatments and precision medicine. These resources were developed to help individuals with advanced cancer better understand emerging therapies and make informed decisions about their care.